✦ LIBER ✦
Brachytherapy Boost for Gleason (GS) 7 Intermediate-Risk Prostate Adenocarcinoma Yields Excellent Biochemical Control and May Eliminate Therapeutic Benefit of Hormonal Therapy
✍ Scribed by Shasha, D.; Nabhani, T.; Mourad, W.F.; Patel, S.; Lukens, J.N.; Gámez, M.; Katsoulakis, E.; Patel, R.; Concert, C.; Ryniak, M.; Shourbaji, R.A.; Shah, N.; Santoro, J.; Ambrose, R.; Dolan, J.; Woode, R.; Goluboff, E.; Dinlenc, C.; Salant, R.L.; Harrison, L.B.
- Book ID
- 127057407
- Publisher
- Elsevier Science
- Year
- 2014
- Tongue
- English
- Weight
- 78 KB
- Volume
- 90
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.